InvestorsHub Logo
Followers 38
Posts 5017
Boards Moderated 2
Alias Born 08/05/2002

Re: errata post# 4898

Thursday, 04/21/2016 1:05:12 PM

Thursday, April 21, 2016 1:05:12 PM

Post# of 9141
Errata,

Licensing is still the strategy. No way they intend to build any type of manufacturing facility to go it alone there. Can you imagine Dahl seeking funding for manufacturing after potentially finishing a feed/food ingredient ?? ROFLMAO .... would take decades.

And yes you generally need something tangible to show a potential licensee why they need your product. But other qualified companies need to get paid to do the development work needed (see the update). Which takes ZIVO raising money. It is obvious Dahl cannot sell the idea. So it drags on and on forever.

At this juncture I believe that ZIVO does have plenty of tangible lab and now field tested proof. The safety studies IMO are formality. I doubt there is any toxicity. IMO it is whether or not there is evidence the ingredient does something of value (which the research says it does) for the end consumer and can it be produced and sold profitably.

I still advocate a JV with a company that has the expertise and can do the work from beginning to end ..... it is a no brainer for a company like ZIVO for one vertical to gain some traction in the market and a name for itself. ZIVO contributes the IP and a % of the JV in exchange for the expertise (i.e. sweat equity so to speak) to drive the vertical to completion. The partner has a vested interest in seeing their contribution pay off by generating revenues and profits. A fractional % of a JV producing revenue is more than ALL of NOTHING. Which is what we have now. By the time the first candidate gets to commercial stage ... if ever ... the stock likely will be diluted to death. It is presently at a stage where it would take significant profits to dent the per share number with any significance which limits upside potential .... which of course makes it far less attractive to me. And since per share price is near all time lows, any dilution is significant which further weighs on stock price.

Only thing interesting in the update to me was the mention of a feed pellet ...... but didn't mention who is doing that.

Once harvested, the algal biomass is freeze-dried and then processed into a feed pellet. The Company will begin in vivo safety testing of the feed pellet once enough biomass is harvested to support a large animal study. Tentatively, the start of an in vivo safety study is scheduled for early June, based on projected volumes of biomass produced at the Vero Beach facility. The results of this first safety study are applicable to both animal and human applications.

It isn't ZIVO and I'm certain it isn't any of the entities mentioned in the PR. And for the bovine feed ingredient .... anyone paying attention would know there is a need to control the release of the ingredient so there is some expertise and technology that has to go into it. So who is ZIVO working with to produce the feed pellet ??

So we shall see but most of my time and money is working on other companies presently. Many fertile playgrounds elsewhere.

Amigo Mike
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZIVO News